These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 21742679

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of the NCCLS extended-spectrum beta-lactamase confirmation methods for Escherichia coli with isolates collected during Project ICARE.
    Tenover FC, Raney PM, Williams PP, Rasheed JK, Biddle JW, Oliver A, Fridkin SK, Jevitt L, McGowan JE, Project ICARE.
    J Clin Microbiol; 2003 Jul; 41(7):3142-6. PubMed ID: 12843054
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M, Dandache I, Araj GF, Wakim R, Kanj S, Kanafani Z, Khairallah M, Sabra A, Shehab M, Dbaibo G, Matar GM.
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L, Lantero M, de Diego I, Alvarez M, Zarazaga M, Torres C.
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [Abstract] [Full Text] [Related]

  • 7. Beta-lactamase characterization in Escherichia coli isolates with diminished susceptibility or resistance to extended-spectrum cephalosporins recovered from sick animals in Spain.
    Briñas L, Moreno MA, Teshager T, Zarazaga M, Sáenz Y, Porrero C, Dominguez L, Torres C.
    Microb Drug Resist; 2003 Dec; 9(2):201-9. PubMed ID: 12820806
    [Abstract] [Full Text] [Related]

  • 8. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.
    Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson GJ, Williams PP, Brittain KL, Oliver A, McGowan JE, Tenover FC.
    J Clin Microbiol; 2001 Aug; 39(8):2864-72. PubMed ID: 11474005
    [Abstract] [Full Text] [Related]

  • 9. Molecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States.
    Shaheen BW, Nayak R, Foley SL, Kweon O, Deck J, Park M, Rafii F, Boothe DM.
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5666-75. PubMed ID: 21947397
    [Abstract] [Full Text] [Related]

  • 10. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
    Haldorsen B, Aasnaes B, Dahl KH, Hanssen AM, Simonsen GS, Walsh TR, Sundsfjord A, Lundblad EW.
    J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Emergence and dominance of CTX-M-15 extended spectrum beta-lactamase among Escherichia coli isolates from children.
    Réjiba S, Mercuri PS, Power P, Kechrid A.
    Microb Drug Resist; 2011 Jun; 17(2):135-40. PubMed ID: 21288137
    [Abstract] [Full Text] [Related]

  • 13. Reduced Susceptibility to Cefepime in Clinical Isolates of Enterobacteriaceae Producing OXA-1 Beta-Lactamase.
    Torres E, López-Cerero L, Rodríguez-Martínez JM, Pascual Á.
    Microb Drug Resist; 2016 Mar; 22(2):141-6. PubMed ID: 26295796
    [Abstract] [Full Text] [Related]

  • 14. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital.
    Kim JY, Park YJ, Kim SI, Kang MW, Lee SO, Lee KY.
    J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971
    [Abstract] [Full Text] [Related]

  • 15. Molecular characterization of plasmids encoding CTX-M-15 beta-lactamases from Escherichia coli strains in the United Kingdom.
    Karisik E, Ellington MJ, Pike R, Warren RE, Livermore DM, Woodford N.
    J Antimicrob Chemother; 2006 Sep; 58(3):665-8. PubMed ID: 16870648
    [Abstract] [Full Text] [Related]

  • 16. Characterization of beta-lactamases responsible for resistance to extended-spectrum cephalosporins in Escherichia coli and Salmonella enterica strains from food-producing animals in the United Kingdom.
    Liebana E, Gibbs M, Clouting C, Barker L, Clifton-Hadley FA, Pleydell E, Abdalhamid B, Hanson ND, Martin L, Poppe C, Davies RH.
    Microb Drug Resist; 2004 Sep; 10(1):1-9. PubMed ID: 15140388
    [Abstract] [Full Text] [Related]

  • 17. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
    Jeong SH, Bae IK, Kwon SB, Lee JH, Song JS, Jung HI, Sung KH, Jang SJ, Lee SH.
    J Appl Microbiol; 2005 Sep; 98(4):921-7. PubMed ID: 15752339
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK.
    Doumith M, Ellington MJ, Livermore DM, Woodford N.
    J Antimicrob Chemother; 2009 Apr; 63(4):659-67. PubMed ID: 19233898
    [Abstract] [Full Text] [Related]

  • 20. Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
    Mendonça N, Leitão J, Manageiro V, Ferreira E, Caniça M.
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1946-55. PubMed ID: 17371815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.